FDA approves a second Alzheimer’s drug that can slow the disease by several months
WASHINGTON (AP) — FDA approves a second Alzheimer’s drug that can slow the disease by several months.
© Copyright The Associated Press. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of The Associated Press.
